Abstract:Social workers are often involved with patients and families around adherence, both to clinic appointments as well as to the medication regimen. An evidence-based practice project was created and implemented to determine the efficacy of electronic reminders such as text messaging on adherence. The implications of improving adherence can positively impact the patient on an individual level as well as reduce costs and increase revenue at a systems level.
“…The drug data sheet provides indications concerning what to do if an administration is missed and information about the main side effects. The purpose of the data sheet is to provide essential information intended to increase treatment adherence by ensuring the greater involvement of the patients 35–39 and sensitising them to the need to respect their prescribed treatment regimen. 40,41 Figure 1.Weekly diary page.…”
Purpose The aim of this study was to verify whether the distribution of a treatment diary by a pharmacist could influence the adherence to oral treatment with imatinib, nilotinib, and dasatinib in patients with chronic myeloid leukaemia. Methods The level of adherence was calculated using the received daily dose/prescribed daily dose ratio and compared between patients who used a diary and those who did not. Results Forty-four (35.8%) of 123 patients with chronic myeloid leukaemia completed the diary: 20 (45.4%) receiving imatinib, 17 (38.6%) receiving nilotinib, and seven (15.9%) receiving dasatinib. Treatment adherence with the diary calculated using received daily dose/prescribed daily dose method was 93.6% (imatinib 94.9%, nilotinib 91.1%, and dasatinib 95.8%). Adherence during the period without a diary was 86.5% (84.9, 87.4, and 90%). Adherence was significantly greater with than without a diary (p < 0.0001). Conclusions The findings of this study that, in the case of chronic diseases, direct pharmacist-patient contact is important in order to maintain high levels of adherence, and a treatment diary is a valid means of doing this. According to these data, it is necessary to support similar patient-oriented programmes in order to ensure high levels of adherence and optimize drug management.
“…The drug data sheet provides indications concerning what to do if an administration is missed and information about the main side effects. The purpose of the data sheet is to provide essential information intended to increase treatment adherence by ensuring the greater involvement of the patients 35–39 and sensitising them to the need to respect their prescribed treatment regimen. 40,41 Figure 1.Weekly diary page.…”
Purpose The aim of this study was to verify whether the distribution of a treatment diary by a pharmacist could influence the adherence to oral treatment with imatinib, nilotinib, and dasatinib in patients with chronic myeloid leukaemia. Methods The level of adherence was calculated using the received daily dose/prescribed daily dose ratio and compared between patients who used a diary and those who did not. Results Forty-four (35.8%) of 123 patients with chronic myeloid leukaemia completed the diary: 20 (45.4%) receiving imatinib, 17 (38.6%) receiving nilotinib, and seven (15.9%) receiving dasatinib. Treatment adherence with the diary calculated using received daily dose/prescribed daily dose method was 93.6% (imatinib 94.9%, nilotinib 91.1%, and dasatinib 95.8%). Adherence during the period without a diary was 86.5% (84.9, 87.4, and 90%). Adherence was significantly greater with than without a diary (p < 0.0001). Conclusions The findings of this study that, in the case of chronic diseases, direct pharmacist-patient contact is important in order to maintain high levels of adherence, and a treatment diary is a valid means of doing this. According to these data, it is necessary to support similar patient-oriented programmes in order to ensure high levels of adherence and optimize drug management.
This project explored the effect of an automated appointment reminder system (texts/e-mails/telephone calls) on patient attendance at behavioral health appointments in a federally qualified health care agency in Texas. Appointment reminder systems have been shown to improve attendance rates in behavioral health (Clouse, Williams, & Harmon, 2017; Gajwani, 2014; Molfenter, 2013; Whisenhunt, 2014). It was expected that behavioral appointment attendance which in this agency has been historically low, would increase following implementation of an automated appointment reminder system. A retrospective electronic health record review was completed to compare behavioral health appointment attendance rates before and after implementation of an automated appointment reminder system. Data analysis revealed that no-show rates for behavioral health appointments in the previous appointment reminder system (telephone call reminders) and the recently implemented automated appointment reminder system (texts/e-mails/telephone calls) were comparable with rates of 19.4% and 20.0%, respectively. The difference between the rates was not statistically significant suggesting that the automated appointment reminder system was not effective in improving patient attendance at behavioral health appointments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
